DUSP10 has been also proposed as a target for therapeutic treatment of atherosclerosis, since DUSP10 inhibition reduces NF-κB-induced TNF-α expression and increases TGF-β1 levels in this disease [27]. Here, DUSP10 is linked to atherosclerosis.